On August 24, 2022, Singapore's Ministry of Health announced a relaxation of the country's COVID-related entry restrictions for international travelers. Specifically, as of August 29, travelers who are not fully vaccinated are no longer required to complete a seven-day home isolation period after arrival or complete post-arrival PCR testing. Singapore's announcement is part of a recent rollback of COVID-19 entry requirements by various countries in East Asia, including Japan and South Korea.

Singapore's "Vaccinated Travel Framework"

In April 2022, Singapore launched a "Vaccinated Travel Framework" (VTF) to facilitate the safe resumption of international travel to and from the country. Under the VTF, fully-vaccinated travelers have been allowed to enter Singapore without having to apply for entry approval, take COVID-19 tests, or undergo a home isolation period after arrival.

International travelers who are not fully vaccinated were allowed to enter Singapore, but were required to:

  • Complete pre-arrival COVID testing within two days of departure for Singapore;
  • Undergo a seven-day home isolation period known as a Stay-Home Notice (SHN); and
  • Obtain a negative PCR test upon day 7 of the SHN.

Short-term visitors were also required to secure COVID travel insurance for the duration of their trip.

In addition, non-fully vaccinated Long-Term Pass Holders (LTPHs) and short-term visitors aged 13 and above were required to apply for prior approval in order to enter Singapore.

Updates to the Vaccinated Travel Framework

Under the August 24 announcement, non-fully vaccinated travelers are no longer required to complete the seven-day SHN or obtain a negative PCR test upon completion of the SHN. Entry approval requirements for LTPHs and short-term visitors have also been suspended.

Pre-arrival testing is still required, and short-term visitors must still obtain COVID travel insurance.

To be considered fully vaccinated by the Singaporean government, travelers must have taken at least one dose of Janssen/Johnson & Johnson, or at least 2 doses of AstraZeneca, Covaxin, Moderna, Covishield, Novavax, Pfizer-BioNTech, Sinovac, or Sinopharm. Mixtures and boosters of these vaccines, and recovery from COVID-19 with vaccination, are also acceptable.

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe - Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2020. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.